Used primarily in the pharmaceutical industry, this compound serves as an intermediate in the synthesis of various sulfonamide-based drugs. Its structure is key in developing medications that target bacterial infections, leveraging the sulfamoyl group's antimicrobial properties. Additionally, it finds application in research settings for studying enzyme inhibition, particularly in pathways involving carbonic anhydrase, which is relevant for treating conditions like glaucoma and edema. Its ester group also makes it a candidate for further chemical modifications, enabling the creation of derivatives with potential therapeutic uses.